An investigator-initiated, double-blind, vehicle-controlled pilot study: Assessment for tachyphylaxis to topically occluded halobetasol 0.05% ointment in the treatment of psoriasis-Reference-Cited by-同舟云学术

An investigator-initiated, double-blind, vehicle-controlled pilot study: Assessment for tachyphylaxis to topically occluded halobetasol 0.05% ointment in the treatment of psoriasis

Published:2014-11 Issue:5 Volume:71 Page:954-959.e1
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Czarnowicki Tali,Linkner Rita V.,Suárez-Fariñas Mayte,Ingber Arie,Lebwohl Mark^ORCID

Publisher

Elsevier BV

Subject

Dermatology

Reference24 articles.

1. Psoriasis;Krueger;J Am Acad Dermatol,1984

2. Effectiveness of topical therapy for psoriasis: results of a national survey;Liem;Cutis,1995

3. Utilization of outpatient care for psoriasis;Stem;J Am Acad Dermatol,1996

4. Psoriasis treatment: traditional therapy;Lebwohl;Ann Rheum Dis,2005

5. Tachyphylaxis to the action of topically applied corticosteroids;du Vivier;Arch Dermatol,1975

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Topical Corticosteroids in the Treatment of Vulvar Lichen Sclerosus: A Review of Pharmacokinetics and Recommended Dosing Frequencies;Sexual Medicine Reviews;2022-01

2. Glucocorticoid Resistance: Interference between the Glucocorticoid Receptor and the MAPK Signalling Pathways;International Journal of Molecular Sciences;2021-09-17

3. Long-term topical management of psoriasis: the road ahead;Journal of Dermatological Treatment;2020-02-24

4. Optimized formulation for topical application of a fixed combination halobetasol/tazarotene lotion using polymeric emulsion technology;Journal of Dermatological Treatment;2019-09-26

5. Use of an alternative method to evaluate erythema severity in a clinical trial: difference in vehicle response with evaluation of baseline and postdose photographs for effect of oxymetazoline cream 1·0% for persistent erythema of rosacea in a phase IV study;British Journal of Dermatology;2019-02-27